Status:
COMPLETED
Intrauterine Device Insertion: a Step for High Satisfaction
Lead Sponsor:
Assiut University
Conditions:
Intrauterine Device
Eligibility:
FEMALE
18-49 years
Phase:
NA
Brief Summary
The intrauterine device is a safe, reliable and long-acting reversible contraceptive method. Instrumentation of lower genital mucosa during intrauterine device application provokes pain because it is ...
Eligibility Criteria
Inclusion
- Women aged 18-49 years
- Nonpregnant
- Women did not receive any analgesics or misoprostol in the 24 hours prior to insertion.
Exclusion
- Women with any uterine abnormalities such as congenital anomalies, endometrial lesions, fibroids
- Allergy to Copper.
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT03383432
Start Date
June 1 2019
End Date
August 1 2020
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women Health Hospital - Assiut university
Asyut, Egypt, 71111